Browsing by Author Holmberg, Stig B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)Citation
2010Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancerCoates, Alan; Cole, Bernard; Crivellari, Diana; Gelber, Richard; Gelber, Shari; Goldhirsch, A; Holmberg, Stig B.; Paridaens, Robert; Price, Karen N.; Thurlimann, B.; School of Public Health: Public HealthAdjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment, vol.123, 1,pp 303-310
2008Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study GroupCoates, Alan; Aebi, Stefan; Byrne, Michael J.; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; et, al; Gianni, Lorenzo; Holmberg, Stig B.; Panzini, Ilaria; Snyder, Raymond; School of Public Health: Public HealthAnemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group, Supportive Care in Cancer, vol.16,(1),2008,pp 67-74
2004Body Mass Index As A Prognostic Feature In Operable Breast Cancer: The International Breast Cancer Study Group Experience.Coates, Alan; Berclaz, G; Castiglione-Gertsch, Monica; Collins, John; Erzen, Darja; et, al; Holmberg, Stig B.; Li, S; Lindtner, Jurii; Price, K N; Rudenstam, Carl-Magnus; School of Public Health: Public HealthBody Mass Index As A Prognostic Feature In Operable Breast Cancer: The International Breast Cancer Study Group Experience., Annals of Oncology 2005, vol.15,(6),2004,pp 875-884
2008Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical TrialsCoates, Alan; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron; Gusterson, Barry A.; Holmberg, Stig B.; Lindtner, Jurii; Mallon, Elizabeth; Murray, E.; Pestalozzi, B. C.; Price, Karen N.; Snyder, Raymond; Thurlimann, Beat; Viale, Giuseppe; Zahrieh, David; School of Public Health: Public HealthDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials, Journal of Clinical Oncology, vol.26, 18, 2008,pp 3006-3014
2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, B F; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Golouh, Rastko; Gruber, G; Gusterson, Barry; Holmberg, Stig B.; Lindtner, Jurii; Price, K. N.; Simoncini, Edda; Thurlimann, Beat; School of Public Health: Public HealthExtracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer, Annals of Oncology, vol.19, N/A, 2008,pp 1393-1401
2006Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Lindtner, Jurii; Murray, E.; Pagani, O.; Pestalozzi, B. C.; Price, K. N.; Simoncini, Edda; Zahrieh, David; School of Public Health: Public HealthIdentifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)., Annals of Oncology 2005, vol.17,(6),2006,pp 935-944
2009Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; et al, various; Gelber, Richard D. (Prof); Gelber, Shari; Holmberg, Stig B.; Lindtner, Jurij; Pagani, O.; Price, Karen N.; Simoncini, Edda; Thurlimann, B.; School of Public Health: Public HealthIs adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93., Breast Cancer Research and Treatment, vol.116, 3,pp 491-500
2009Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Collins, John; Crivellari, Diana; Forbes, John F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Price, Karen; Thurlimann, Beat; School of Public Health: Public HealthIs chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93., Breast Cancer Research and Treatment, vol.113,(N/A),2009,pp 137-144
2006Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Gelber, Richard D. (Prof); Gianni, Lorenzo; Goldhirsch, Aron (Prof); Holmberg, Stig B.; Li, Sigui; Panzini, Ilaria; Ravaioli, Alberto; School of Public Health: Public HealthOcular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials., Cancer, vol.106,(3),2006,pp 505-513
2009Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; et al, various; Fey, Martin F.; Gelber, RD; Holmberg, Stig B.; Lindtner, Jurij; Pagani, O.; Price, K. N.; Thurlimann, Beat; School of Public Health: Public HealthPatterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century., Breast Cancer Research and Treatment, vol.117, 2,pp 319-324
2005Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: Long-term observations from international breast caCoates, Alan; Bonetti, Marco; Castiglione-Gertsch, Monica; et, al; Golouh, Rastko; Gruber, G√ľnther; Holmberg, Stig B.; Lindtner, Jurij; Nasi, M. Laura; Price, Aaron; Rudenstam, Carl-Magnus; School of Public Health: Public HealthPrognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: Long-term observations from international breast ca, Journal of Clinical Oncology, vol.23,(28),2005,pp 7089-7097
2006Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.Coates, Alan; Bernhard, Jurg; Campbell, Ian; Crivellari, Diana; Dent, David; et, al; Forbes, John F.; Holmberg, Stig B.; Rey, Piercarlo; Rudenstam, Carl-Magnus; Zahrieh, David; School of Public Health: Public HealthRandomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(3),2006,pp 337-344
2003Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VIICoates, Alan; Bonetti, M; Castiglione-Gertsch, Monica; et, al; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Holmberg, Stig B.; Lindtner, Jurij; Thurlimann, B.; Wallgren, A; School of Public Health: Public HealthRisk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII, Journal of Clinical Oncology, vol.21,(7),2003,pp 1205-1213
2007The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, Bernard; Collins, John; et, al; Gusterson, Barry; Holmberg, Stig B.; Karlsson, Per; Lindtner, Jurij; Murray, E.; Price, Karen N.; School of Public Health: Public HealthThe role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(15),2007,pp 2019-2026
2005Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group ExperienceCoates, Alan; Colleoni, Marco; Erzen, Darja; et, al; Gelber, Richard D. (Prof); Holmberg, Stig B.; Lindtner, Jurii; Mattsson, Jan E.; Rudenstam, Carl-Magnus; Snyder, Raymond; Zahrieh, David; School of Public Health: Public HealthSite of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.23,(7),2005,pp 1390-1400